Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors

Authors

Wen Ping Li, Washington University School of Medicine in St. Louis
Laura A. Meyer, Washington University School of Medicine in St. Louis
David A. Capretto, Washington University School of Medicine in St. Louis
Christopher D. Sherman, Washington University School of Medicine in St. Louis
Carolyn J. Anderson, Washington University School of Medicine in St. LouisFollow

Journal

Cancer Biotherapy & Radiopharmaceuticals

Publication Date

2008

Volume

23

Issue

2

Inclusive Pages

158-171

Document Type

Open Access Publication

DOI

10.1089/cbr.2007.0444

Rights and Permissions

Wen Ping Li, Laura A. Meyer, David A. Capretto, Christopher D. Sherman, and Carolyn J. Anderson. Cancer Biotherapy & Radiopharmaceuticals. April 2008, 23(2): 158-171. doi:10.1089/cbr.2007.0444.

Recommended Citation

Li, Wen Ping; Meyer, Laura A.; Capretto, David A.; Sherman, Christopher D.; and Anderson, Carolyn J., "Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors." Cancer Biotherapy & Radiopharmaceuticals. 23, 2. 158-171. (2008).
https://digitalcommons.wustl.edu/open_access_pubs/2908